Nervgen Pharma (NGEN) Exchange Rate Effect (2025 - 2026)
Nervgen Pharma (NGEN) posted quarterly Exchange Rate Effect of -$72186.3 for Q1 2026, down 552.63% year-over-year from $15948.2 in Q1 2025, and down 552.63% quarter-over-quarter from $15948.2 in Q1 2025.
Nervgen Pharma (NGEN) Exchange Rate Effect (2025 - 2026) Analysis & Trends
Nervgen Pharma (NGEN) has reported Exchange Rate Effect for 2 consecutive years, with -$72186.3 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Nervgen Pharma | 168.25 Mn | 168.25 Mn | - | -1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72,186.26 |
| Mar 31, 2026 | -72,186.26 |
| Mar 31, 2025 | 15,948.24 |
| Mar 31, 2025 | 15,948.24 |